PDCD1 and autoimmune disease: Zhao et al. showed that by using immunotoxic complexes that block PD-1, a reduction in the number of PD-1-positive cells, total T lymphocytes, and especially autoreactive T cells, could be observed in different mouse models of autoimmune disease without negatively affecting normal adaptive immunity [92].